(Q33419062)

English

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma.

scientific article

Statements

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma. (English)
0 references
0 references
Matthew I Milowsky
Christian Dittrich
Ignacio Durán
Satinder Jagdev
Frederick E Millard
Christopher J Sweeney
Dean Bajorin
Linda Cerbone
Walter M Stadler
Melissa Lochheed
Paramita Sen
Matthew Squires
Michael Shi
Cora N Sternberg
30 October 2014
3145-3152

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit